IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 337 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $40,988 | +64.7% | 860 | +49.8% | 0.00% | +50.0% |
| Q1 2024 | $24,883 | -26.7% | 574 | -14.5% | 0.00% | -33.3% |
| Q4 2023 | $33,946 | +27.3% | 671 | +14.1% | 0.00% | 0.0% |
| Q3 2023 | $26,672 | +10.6% | 588 | 0.0% | 0.00% | +50.0% |
| Q2 2023 | $24,126 | +14.4% | 588 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $21,087 | +126.0% | 590 | +138.9% | 0.00% | +100.0% |
| Q4 2022 | $9,329 | -28.2% | 247 | -16.8% | 0.00% | -50.0% |
| Q3 2022 | $13,000 | +30.0% | 297 | +12.9% | 0.00% | +100.0% |
| Q2 2022 | $10,000 | 0.0% | 263 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 267 | -21.5% | 0.00% | 0.0% |
| Q4 2021 | $10,000 | -37.5% | 340 | -27.0% | 0.00% | -50.0% |
| Q3 2021 | $16,000 | +700.0% | 466 | +703.4% | 0.00% | – |
| Q2 2021 | $2,000 | -83.3% | 58 | -78.1% | 0.00% | -100.0% |
| Q1 2021 | $12,000 | -14.3% | 265 | +3.9% | 0.00% | -33.3% |
| Q4 2020 | $14,000 | +133.3% | 255 | +119.8% | 0.00% | +200.0% |
| Q3 2020 | $6,000 | +200.0% | 116 | +182.9% | 0.00% | – |
| Q2 2020 | $2,000 | -91.3% | 41 | -91.6% | 0.00% | -100.0% |
| Q1 2020 | $23,000 | +2200.0% | 490 | +2030.4% | 0.00% | – |
| Q4 2019 | $1,000 | -91.7% | 23 | -89.4% | 0.00% | -100.0% |
| Q3 2019 | $12,000 | +1100.0% | 218 | +847.8% | 0.00% | – |
| Q2 2019 | $1,000 | -98.1% | 23 | -96.6% | 0.00% | -100.0% |
| Q1 2019 | $53,000 | +5200.0% | 676 | +2839.1% | 0.01% | – |
| Q4 2018 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 23 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 23 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 23 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 23 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 23 | 0.0% | 0.00% | -100.0% |
| Q4 2016 | $1,000 | -50.0% | 23 | -74.7% | 0.00% | 0.0% |
| Q1 2016 | $2,000 | -80.0% | 91 | -49.2% | 0.00% | -85.7% |
| Q4 2015 | $10,000 | – | 179 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
| Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
| Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
| SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
| Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
| Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
| Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
| ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |